Horizon Therapeutics Public Limited Company ( HZNP) - Stock Earnings

HZNP Quarterly earnings

DateEarningsRevenue
2022Q3 135.8 million USD 925.4 million USD
2022Q4 120.4 million USD 942.0 million USD
2023Q1 54.7 million USD 832.1 million USD

HZNP Yearly earnings

DateEarningsRevenue
2020 389.8 million USD 2.2 billion USD
2021 534.5 million USD 3.2 billion USD
2022 521.5 million USD 3.6 billion USD

HZNP

Price: $116.30

52 week price:
57.84
116.30

Earnings Per Share: 5.66 USD

P/E Ratio: 61.86

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: Ireland

Volume: 2.6 million

Ebitda: 44.4 million

Market Capitalization: 23.4 billion

Links: